BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32021417)

  • 1. Circulating Tumor Cell Detection In Epithelial Ovarian Cancer Using Dual-Component Antibodies Targeting EpCAM And FRα.
    Li N; Zuo H; Chen L; Liu H; Zhou J; Yao Y; Xu B; Gong H; Weng Y; Hu Q; Song Q; Peng M; Cheng Y
    Cancer Manag Res; 2019; 11():10939-10948. PubMed ID: 32021417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined use of EpCAM and FRα enables the high-efficiency capture of circulating tumor cells in non-small cell lung cancer.
    Chen L; Peng M; Li N; Song Q; Yao Y; Xu B; Liu H; Ruan P
    Sci Rep; 2018 Jan; 8(1):1188. PubMed ID: 29352248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folate-appended cyclodextrin carrier targets ovarian cancer cells expressing the proton-coupled folate transporter.
    Saito S; Koya Y; Kajiyama H; Yamashita M; Kikkawa F; Nawa A
    Cancer Sci; 2020 May; 111(5):1794-1804. PubMed ID: 32154964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients.
    Deng G; Herrler M; Burgess D; Manna E; Krag D; Burke JF
    Breast Cancer Res; 2008; 10(4):R69. PubMed ID: 18687126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Automatic Platform Based on Nanostructured Microfluidic Chip for Isolating and Identification of Circulating Tumor Cells.
    Jou HJ; Chou LY; Chang WC; Ho HC; Zhang WT; Ling PY; Tsai KH; Chen SH; Chen TH; Lo PH; Chen M; Hsu HT
    Micromachines (Basel); 2021 Apr; 12(5):. PubMed ID: 33919456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual Targeting of Epithelial Ovarian Cancer Via Folate Receptor α and the Proton-Coupled Folate Transporter with 6-Substituted Pyrrolo[2,3-
    Hou Z; Gattoc L; O'Connor C; Yang S; Wallace-Povirk A; George C; Orr S; Polin L; White K; Kushner J; Morris RT; Gangjee A; Matherly LH
    Mol Cancer Ther; 2017 May; 16(5):819-830. PubMed ID: 28138029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The feasibility of folate receptor alpha- and HER2-targeted intraoperative fluorescence-guided cytoreductive surgery in women with epithelial ovarian cancer: A systematic review.
    de Jong JM; Hoogendam JP; Braat AJAT; Zweemer RP; Gerestein CG
    Gynecol Oncol; 2021 Aug; 162(2):517-525. PubMed ID: 34053747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of an optimized CTC detection model consisting of EpCAM, MUC1 and WT1 in epithelial ovarian cancer and its correlation with clinical characteristics.
    Wang T; Gao Y; Wang X; Tian J; Li Y; Yu B; Huang C; Li H; Liang H; Irwin DM; Tan H; Guo H
    Chin J Cancer Res; 2022 Apr; 34(2):95-108. PubMed ID: 35685992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved ovarian cancer EMT-CTC isolation by immunomagnetic targeting of epithelial EpCAM and mesenchymal N-cadherin.
    Po JW; Roohullah A; Lynch D; DeFazio A; Harrison M; Harnett PR; Kennedy C; de Souza P; Becker TM
    J Circ Biomark; 2018; 7():1849454418782617. PubMed ID: 30013673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of Circulating Tumor Cells from Multiple Epithelial Cancers with ApoStream(®) for Detecting (or Monitoring) the Expression of Folate Receptor Alpha.
    O'Shannessy DJ; Davis DW; Anderes K; Somers EB
    Biomark Insights; 2016; 11():7-18. PubMed ID: 26848256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EpCAM-independent capture of circulating tumor cells with a 'universal CTC-chip'.
    Chikaishi Y; Yoneda K; Ohnaga T; Tanaka F
    Oncol Rep; 2017 Jan; 37(1):77-82. PubMed ID: 27840987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of circulating tumour cells in patients with epithelial ovarian cancer by a microfluidic system.
    Rao Q; Zhang Q; Zheng C; Dai W; Zhang B; Ionescu-Zanetti C; Lin Z; Zhang L
    Int J Clin Exp Pathol; 2017; 10(9):9599-9606. PubMed ID: 31966837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of circulating tumor cell (CTC) detection rates with epithelial cell adhesion molecule (EpCAM) and cell surface vimentin (CSV) antibodies in different solid tumors: a retrospective study.
    Gao Y; Fan WH; Song Z; Lou H; Kang X
    PeerJ; 2021; 9():e10777. PubMed ID: 33717672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity and specificity of folate receptor α-positive circulating tumour cells in gastric cancer.
    Cao B; Liu L; Zhang R; Dong H; Shen J
    Postgrad Med J; 2024 Jan; 100(1180):112-119. PubMed ID: 37973392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and future role of circulating tumor cells in patients with epithelial ovarian cancer.
    Van Berckelaer C; Brouwers AJ; Peeters DJ; Tjalma W; Trinh XB; van Dam PA
    Eur J Surg Oncol; 2016 Dec; 42(12):1772-1779. PubMed ID: 27265041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate receptor alpha protein expression in ovarian serous cystadenocarcinoma tumors of The Cancer Genome Atlas: exploration beyond single-agent therapy.
    Persenaire C; Bitler BG; Corr BR
    medRxiv; 2024 Apr; ():. PubMed ID: 38645083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of rare circulating tumor cells by folate receptor α ligand-targeted PCR in bladder transitional cell carcinoma and its potential diagnostic significance.
    Qi F; Liu Y; Zhao R; Zou X; Zhang L; Li J; Wang Y; Li F; Zou X; Xia Y; Wang X; Xing L; Li C; Lu J; Tang J; Zhou F; Liu C; Gui Y; Cai Z; Sun X
    Tumour Biol; 2014 Jul; 35(7):7217-23. PubMed ID: 24771263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients.
    Königsberg R; Obermayr E; Bises G; Pfeiler G; Gneist M; Wrba F; de Santis M; Zeillinger R; Hudec M; Dittrich C
    Acta Oncol; 2011 Jun; 50(5):700-10. PubMed ID: 21261508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic strategies targeting folate receptor α for ovarian cancer.
    Mai J; Wu L; Yang L; Sun T; Liu X; Yin R; Jiang Y; Li J; Li Q
    Front Immunol; 2023; 14():1254532. PubMed ID: 37711615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.
    Schneck H; Gierke B; Uppenkamp F; Behrens B; Niederacher D; Stoecklein NH; Templin MF; Pawlak M; Fehm T; Neubauer H;
    PLoS One; 2015; 10(12):e0144535. PubMed ID: 26695635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.